UPDATE 2-Biogen beats estimates on multiple sclerosis therapy sales
July 23, 2019 at 08:09 AM EDT
Drugmaker Biogen Inc beat analysts' estimates for quarterly profit and lifted its 2019 earnings forecast on Tuesday, driven by higher sales of its top-selling multiple sclerosis therapy Tecfidera.